In breast cancer, an elevated basal glycolysis is associated with oncogenic HER2- or estrogen receptor (ER) status [25]; however, the molecular aspects of the oncogenic control in these process remains poorly understood. The gene discussed is ERBB2; the disease is breast cancer.